(Q46963351)

English

Folic acid supplementation during methotrexate immunosuppression is not associated with early toxicity, risk of acute graft-versus-host disease or relapse following hematopoietic transplantation

scientific article published in April 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16501595

Folic acid supplementation during methotrexate immunosuppression is not associated with early toxicity, risk of acute graft-versus-host disease or relapse following hematopoietic transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16501595

immunosuppression

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16501595

5

object named as

R Storb

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

author name string

K Robien

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16501595

M M Schubert

2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16501595

Y Yasui

3

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16501595

P Martin

4

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16501595

C M Ulrich

7

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16501595

language of work or name

0 references

publication date

1 April 2006

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16501595

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16501595

37

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16501595

7

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16501595

687-692

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16501595

Folate during antifolate chemotherapy: what we know... and do not know.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705303

21 January 2018

Mucositis after allogeneic hematopoietic stem cell transplantation: a cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705303

21 January 2018

Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705303

21 January 2018

Hematologic aspects of myeloablative therapy and bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705303

21 January 2018

Clinical assessment scale for the rating of oral mucosal changes associated with bone marrow transplantation. Development of an oral mucositis index

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705303

21 January 2018

Pharmacogenetics of methotrexate: toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705303

21 January 2018

Predictors of oral mucositis in patients receiving hematopoietic cell transplants for chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705303

21 January 2018

Methylenetetrahydrofolate reductase genotype affects risk of relapse after hematopoietic cell transplantation for chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705303

21 January 2018

Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705303

21 January 2018

Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705303

21 January 2018

Folate supplementation during methotrexate treatment of patients with rheumatoid arthritis. An update and proposals for guidelines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705303

21 January 2018

Phase II study of pemetrexed disodium (Alimta) administered with oral folic acid in patients with advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705303

21 January 2018

Phase II Study of Pemetrexed With and Without Folic Acid and Vitamin B12 as Front-Line Therapy in Malignant Pleural Mesothelioma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705303

21 January 2018

Pemetrexed (Alimta®): a novel multitargeted antifolate agent

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705303

21 January 2018

Weekly lometrexol with daily oral folic acid is appropriate for phase II evaluation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705303

21 January 2018

Folic acid supplements in vitamin tablets: a determinant of hematological drug tolerance in maintenance therapy of childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705303

7 January 2021

based on heuristic

inferred from DOI database lookup

Shortage of intravenous multivitamin solution in the United States

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705303

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705303

7 January 2021

based on heuristic

inferred from DOI database lookup

A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705303

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination of anticancer agents with folic acid in the treatment of murine leukaemia P388

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705303

7 January 2021

based on heuristic

inferred from DOI database lookup

Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705303

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1705303

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16501595

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16501595

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46963351&oldid=2208309531"